Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
32
33
Next >
Week in Review: VectorBuilder Plans $500 Million Gene Therapy Delivery CDMO in Guangzhou
April 16, 2022
Tickers
BGNE
VTGN
Tags
Market News
Healthcare
Pharma/Biotech
From
TalkMarkets
4 Out Of 5 Marijuana Stock Categories Kept Falling, Week Ending April 14
April 16, 2022
Tickers
ACB
BTI
BUD
MO
Tags
Pharma/Biotech
Stocks / Equities
Consumer Goods
From
TalkMarkets
Can Simulations Plus Stock Maintain Its Impressive Growth?
April 15, 2022
Tickers
SLP
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Healthcare Stocks Finding Buyers Again, MRNA, VERU, BNTX
April 14, 2022
Tickers
BNTX
MRNA
VERU
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
The Canadian Cannabis Report - Monday, April 11
April 11, 2022
Tickers
CNBS
FLWPF
HEXO
MJ
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Performance Comparisons Of The 5 Cannabis Sector Categories
April 10, 2022
Tickers
CGC
CURLF
CYBN
GHRS
Tags
Pharma/Biotech
Stocks / Equities
Consumer Goods
From
TalkMarkets
The Hawks Are Circling - How to Protect Your Portfolio
April 10, 2022
Tickers
IYT
SMH
SPX
VTV
Tags
Pharma/Biotech
Utilities
Market News
From
TalkMarkets
Week In Review: Harbour BioMed Signs $350 Million Out-license Deal For Bispecific With AstraZeneca
April 09, 2022
Tickers
AZN
SLS
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Good Entry Point for Biotech Stocks
April 04, 2022
Tickers
ABBV
BMY
IWM
MRK
Tags
Market News
ETFs
Healthcare
From
TalkMarkets
The Canadian Cannabis Report - Monday, April 4
April 04, 2022
Tickers
CNBS
HEXO
MJ
THCX
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Acadia: Helping With Alzheimers And Parkinsons
April 03, 2022
Tickers
ACAD
XBI
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
If The Market Holds Watch Bitcoin And The Biotech Space
April 03, 2022
Tickers
BITCOMP
IBB
IWM
SPY
Tags
Pharma/Biotech
Cryptocurrencies
bitcoin
From
TalkMarkets
March Madness, Revisiting The First Quarter
April 03, 2022
Tickers
DBA
EEM
EFA
EWZ
Tags
ETFs
Transportation
Consumer Goods
From
TalkMarkets
Week In Review: RemeGen Raises $410 Million In Shanghai IPO For mAbs/Dual Therapies
April 02, 2022
Tickers
LLY
PYXS
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
March Update: Psychedelic Compounds-Based Drug Stocks Index Went Down -19%
April 01, 2022
Tickers
ALID
CMPS
CRBP
CYBN
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Biotech Funds and ETFs Continue to Lag
March 28, 2022
Tickers
ABBV
AZN
BMY
LLY
Tags
ETFs
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
The Canadian Cannabis Report - Monday, March 28
March 28, 2022
Tickers
ACB
ALEAF
CBWTF
CGC
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Psychedelic Compounds-Based Drug Stocks Down Slightly This Past Week
March 27, 2022
Tickers
GHRS
MNMD
NUMIF
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal
March 26, 2022
Tickers
BVNRY
LLY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Healthy Pharma Favorites
March 25, 2022
Tickers
BMY
MRK
OGN
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
5 Stocks in Nasdaq ETF That Gained Most Last Week
March 22, 2022
Tickers
BIDU
DOCU
JD
MELI
Tags
Market News
Technology
Stocks / Equities
From
TalkMarkets
Bull of the Day - Meridian Bioscience (VIVO)
March 21, 2022
Tickers
VIVO
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
The Canadian Cannabis Report- Monday, March 21
March 21, 2022
Tickers
ACB
ALEAF
CGC
CNBS
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Psychedelic Compounds-Based Drug Stocks Index Bounces Back
March 20, 2022
Tickers
CMPS
CYBN
FTRP
MNMD
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: A Possible Solution To US De-Listing Of China Biopharmas?
March 19, 2022
Tickers
IMAB
PFE
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Vaccine Makers Continue to Post Big Stock Price Gains
March 17, 2022
Tickers
BNTX
MRNA
PFE
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
BioCryst Continues To Develop A Strong Pipeline
March 15, 2022
Tickers
BCRX
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Best Biotech Stocks To Buy In 2022
March 15, 2022
Tickers
AMGN
AXSM
BMY
GMAB
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
The Canadian Cannabis Report - Monday, March 14
March 14, 2022
Tickers
CNBS
MJ
NEPT
THCX
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Merck (MRK) Outperforms Industry, What's In Store For 2022?
March 07, 2022
Tickers
AZN
GMDA
MRK
VRTX
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.